Cerliponase alfa for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 27 Nov 2019

Cite this